Organismal ploidy state and environmental stress impact the mutational spectrum and the mutational rate. The human fungal pathogen Candida albicans, serves as a clinically relevant model for studying the interaction between eukaryotic ploidy and stress-induced mutagenesis. In this study, we compared the rates and types of genome perturbations in diploid and tetraploid C. albicans following exposure to two classes of antifungal drugs, azoles and echinocandins. We measured mutations at three different scales: point mutation, loss-ofheterozygosity (LOH), and genome size changes in cells treated with fluconazole and caspofungin. We find that caspofungin induced higher rates of mutation than fluconazole, likely an indirect result from the stress associated with cell wall perturbations rather than an inherent genotoxicity. Furthermore, we found disproportionately elevated rates of LOH and genome size changes in response to both antifungals in tetraploid C. albicans compared to diploid C.
Introduction
Mutations are the source material for adaptation. The mutational spectrum ranges from small-scale mutations, such as base substitutions and indels, to larger-scale mutational events such as gross chromosomal rearrangements and aneuploidy. Despite the presence of DNA repair mechanisms, all organisms incur mutations at a low level (Friedberg 2003) ; however, the rate of mutagenesis increases under stressful environments in both prokaryotes and eukaryotes (Tenaillon et al. 2004; Foster 2008; Petrosino et al. 2009; Forche et al. 2011; Maharjan and Ferenci 2017; Liu and Zhang 2019) . For example, in yeast, the addition of inorganic salts, such as lithium chloride, increases the mutation rate by 3.5-fold (Liu and Zhang 2019) . While stress increases mutational rates, it also shifts the mutational spectrum. Nutrient depletion, including phosphorus and nitrogen deficiencies, not only increase the mutation rate by seven-fold in E. coli but the types of mutations shift from indels to base substitutions (Maharjan and Ferenci 2017) . Taken together, stressful environments can induce mutagenesis to provide increased genetic variation for natural selection to ultimately act upon.
While environmental stress impacts the rates and types of mutation, it is not the only factor that influences the mutational landscape. Ploidy, the number of sets of chromosomes an organism has, is an important determinant of the mutational spectrum available to an organism (Selmecki et al. 2015; Sharp et al. 2018) . The human fungal pathogen, C. albicans, serves as a clinically-relevant model for studying the interaction between eukaryotic ploidy and stressinduced mutagenesis because of two key properties: the mutational rate and spectrum shifts extensively when C. albicans is exposed to stress (Forche et al. 2011) and C. albicans exists across a range of ploidy states -from haploid to polyploid (Rustchenko 2007; Selmecki et al. 2010; Hickman et al. 2015; Todd et al. 2017) The ploidy state in which Candida albicans is isolated impacts its allelic phenotypes and genome stability. For example, C. albicans haploids have been isolated from a variety of in vitro stressors, such as the halo of a common antifungal susceptibility test and are mostly transient.
They serve as a mechanism by which C. albicans can purge deleterious mutations, as the homozygous state incurs a fitness cost (Hickman et al. 2013) . C. albicans is most-frequently isolated as a heterozygous diploid state (Jones et al. 2004; Braun et al. 2005; Abbey et al. 2011; Muzzey et al. 2013 ). In the diploid state, C. albicans frequently generates gross-chromosome rearrangements and maintains these large-scale mutations in laboratory and clinical isolates (Selmecki et al. 2009 (Selmecki et al. , 2010 Ford et al. 2015; Todd et al. 2017 Todd et al. , 2019 . Interestingly, diploid C. echinocandins, which target the inner cell wall, because they are most commonly used to treat C. albicans infection (Pappas et al. 2016; Perfect 2017) . Antifungal drugs may be mutagenic, as fluconazole exposure increases the rate of LOH in C. albicans (Forche et al. 2011 ) and induces aneuploidy (Harrison et al. 2014) , aneuploidy is commonly with azole-resistant clinical isolates (Selmecki et al. 2006 (Selmecki et al. , 2009 With only a limited number of antifungals that can effectively treat these infections (Pappas et al. 2016 ) , a deeper understanding of drug-induced mutagenesis is vital.
Unlike bacteria, which rapidly acquires drug resistance through plasmid transfer and horizontal gene transfer, resistance-associated mutations in C. albicans only arises through de novo events. Fluconazole resistance rates range from 1-86% in Candida species (Tsay et al. 2017; Pfaller et al. 2019) and can be due to copy number variation, homozygosis of drugresistant alleles (Pfaller 2012; Ford et al. 2015; Morschhäuser 2016) and aneuploidy, including the formation of isochromosome 5L (Coste et al. 2006; Selmecki et al. 2006 Selmecki et al. , 2009 . In contrast, resistance to caspofungin, a commonly used echinocandin, is limited to single point mutations in FKS1, the gene encoding the drug target of echinocandins, a glucan synthase enzyme, (Pfaller 2012; Sanguinetti et al. 2015) While drug-induced mutagenesis has been studied in diploid C. albicans exposed to fluconazole, not much is known about how ploidy impacts this phenomena and how other clinically relevant antifungal drugs impact C. albicans genome stability. Though these dynamics have yet to be investigated, understanding them has implications for the evolution of drug-resistance in this common human opportunistic fungal pathogen.
In this study, we asked whether diploid and tetraploid C. albicans generate the same type of genomic perturbations when exposed to two classes of antifungal drugs. To address this question, we measured LOH rates and genome size changes in both diploid and tetraploid C. albicans exposed to fluconazole and to caspofungin. We found that regardless of ploidy, caspofungin was more mutagenic, through an indirect mechanism likely a result of cell wall stress, rather than genotoxicity. Additionally, we found that in the tetraploid state, C. albicans showed elevated rates of LOH and genome size changes in response to both antifungals compared to diploid C. albicans. These findings suggest that an interaction between ploidy state and the stress environment impacts the magnitude of stress-induced mutagenesis. These results have evolutionary and clinically relevant implications for how fungal pathogens generate adaptive mutations and how these mutations facilitate antifungal resistance.
Results

Antifungal drug susceptibility is similar for diploids and tetraploids
First we assessed if antifungal drug susceptibility differs between diploid and tetraploid C. albicans, and determined the minimum inhibitory concentration (MIC) of fluconazole (FLU) and caspofungin (CAS) for isogenic diploid and tetraploid C. albicans. We did not obsereve any differences in drug susceptibility between the two strains and measured the MIC for fluconazole to be ~1 µg/mL and caspofungin to be <0.25 µg/mL ( Fig. S1A & B) . To determine the cell viability of these two ploidy states after antifungal drug exposure, we measured colony forming units (CFUs) following 24-hour exposure to 1 and 10 µg/mL fluconazole and 0.25 and 2.5 µg/mL caspofungin, representing 1x and 10x the MIC. While we do not detect significant reduction in the number of CFUs following exposure to fluconazole compared to the no drug treatment, we do see that exposure to fluconazole substantially slows diploid and tetraploid growth rates, particularly at high concentrations (S1C & S1D). We find that exposure to caspofungin reduces the number of viable CFUs more severely than fluconazole, regardless of ploidy ( Fig. 1A & B ). Interestingly, the low concentration of caspofungin inhibited cell growth to a greater degree than higher concentrations for both diploid and tetraploids C. albicans, a phenomenon coined the "the paradoxical effect of echinocandins" (Wagener and Loiko 2017) . When we compare CFUs between tetraploid to diploid C. albicans, we observe a 50% reduction in tetraploids in the no drug treatment and detect a similar reduction in fluconazole, regardless of concentration (Fig.   1C ). In contrast, both doses of caspofungin resulted in >90% reduction in tetraploid CFUs compared to diploid CFUs, suggesting that the tetraploid C. albicans is more sensitive to caspofungin than the diploid state.
Tetraploid mutation rates are differentially impacted by antifungal drugs compared to diploids
Given that short-term exposure impacts cell viability and growth of diploid and tetraploid C. albicans, we next wanted to investigate if antifungal drug exposure increased mutations rates. Since mutations can range from small scale, such as single nucleotide mutations, to large scale, such as gene conversion events and aneuploidy, we measured both the rates of point mutations using a his4-G929T (on Chr4) reversion assay (Forche et al. 2011) as well as a lossof-heterozygosity (LOH) at the GAL1 locus on Chr1 in diploid and tetraploid C. albicans following exposure to low and high concentrations of fluconazole and caspofungin. The reversion rate in the no drug treatment was extremely low for both diploid (~4 x 10 10 events/cell division) and tetraploid (~12 x 10 10 events/cell division) strains, albeit the mutations rate is slightly higher in tetraploid C. albicans. Exposure to antifungal drugs either did not change the mutation rate, or only modestly increased it (Table S1 ). For example, exposure to the high concentrations of fluconazole and caspofungin only increased the tetraploid mutation rate by two-fold. It should be noted that the rarity of revertants, coupled with the fungicidal nature of caspofungin, made it technically difficult to capture reversion events in all our experiments.
While point mutations are quite rare in C. albicans, large-scale genomic rearrangements occur more frequently and are easily detected (Forche et al. 2011; Hickman et al. 2015; Ene et al. 2018) . To determine how exposure to antifungal drugs impacts the rate of large-scale rearrangements in diploid and tetraploid C. albicans, we measured the rate of GAL1 loss-ofheterozygosity in both ploidy states. In diploid C. albicans, both concentrations of caspofungin significantly increased the rate of LOH compared to the no drug treatment, but exposure to fluconazole did not ( Fig. 2A ). In contrast, in tetraploid C. albicans, the rate of LOH was significantly higher in both fluconazole and caspofungin treatments compared to the no drug treatment ( Fig. 2B ). However, the degree to which the antifungal drugs elevated the rate of LOH differed; exposure to either concentration of fluconazole increased the LOH rate by ~3-fold, whereas exposure to caspofungin increased the LOH rate by ~100-fold compared to the no drug treatment.
We also observe significant differences in the overall rate of LOH between the diploid and tetraploid state (Fig. 2C ). In the no drug treatment, the rate of LOH is 1.0 x10 -5 events/cell division in the diploid state ( Fig. 2A , dashed line) compared to 2.9 x10 -4 events/cell division in the tetraploid state ( Fig. 2B , dashed line) -an ~30-fold difference, (Fig. 2C , dashed line), in accordance with previously published results (Hickman 2015) . If there is not a ploidy-specific interaction with antifungal drugs on LOH rates, then we would expect to see a similar 30-fold increase of tetraploid LOH across the drug treatments. Indeed, this is pattern is observed in caspofungin when we compare the rate of LOH between the tetraploid and diploid, where the average fold-change in tetraploid LOH is ~40 and is not statistically different than the no drug treatment ( Fig. 2C , green bars). In contrast, both fluconazole concentrations have a >60-foldchange in tetraploid LOH, which is statistically different than the no drug treatment ( Fig 2C, purple bars). Furthermore, we detect a significant interaction between C. albicans ploidy state and antifungal drugs on LOH rates ('interaction' p = 0.0019, two-way ANOVA) in addition to the individual impact from either ploidy (p = 0.0024, two-way ANOVA) or drug treatment (p = 0.0011, two-way ANOVA) ( Fig. S2 ).
Regardless of ploidy state, we observed that exposure to caspofungin significantly increases LOH rates, a surprising result given that there is little supportive evidence for its genotoxicity, though some evidence suggesting it induces apoptosis in cells (Hao et al. 2013) .
To test whether the dramatic increase in LOH in caspofungin-treated C. albicans is directly related to is antifungal characteristics and potential genotoxicity or if the increased LOH is an indirect consequence of cell-wall stress, we exposed diploid and tetraploid C. albicans to 100ug/mL calcofluor white (Walker et al. 2008 ), a cell-wall perturbing agent at a concentration that inhibited growth to a similar degree as the low concentration of caspofungin ( Fig. S3 ). We found that exposure to calcofluor white elevated the rate of LOH in both diploid ( Fig. 2A ) and tetraploid ( Fig. 2B ) C. albicans by 100-fold compared to the no drug treatment. This dramatic increase in LOH associated with calcofluor white is comparable to that of caspofungin and suggests that increased LOH is an indirect consequence of cell wall stress. Interestingly, when we compared the LOH rate between tetraploid and diploid C. albicans, there was only an 11-fold change between ploidy states, a statistically smaller difference than the no drug treatment (Fig.   2C , grey bar) and may indicate that the diploid state is more susceptible to cell wall stress than the tetraploid state.
Genome size changes occur in response to antifungal drugs regardless of ploidy
Since exposure to antifungal drugs increased the rates of mutagenesis in either one or both ploidy states, we next examined whether genome size changes occur in response to these treatments. We measured total genome size of at least 80 single colony derivatives of diploid and tetraploid C. albicans after 24-hour exposure to antifungal drugs. We detect significant genome size changes across the set of single colonies isolated from both diploid ( Fig. 3A) and tetraploid ( Fig. 3B ) C. albicans following exposure to nearly all antifungal drugs treatments compared to genome size distribution obtained from a similar number of isolates derived from the no drug treatment ( Fig. 3A & B , grey shading). For diploid C. albicans, most genome size changes detected were modest increases in total DNA content. In particular, the high concentration of fluconazole and low concentration of caspofungin resulted in higher genome size in ~8% and ~20% of single colony isolates, respectively ( Fig. 3C ). Interestingly, these increases in genome size are likely transient, as we do not detect deviations from diploidy in isolates that have been exposed to antifungal drugs for longer time periods ( Fig. S4A & C) . In contrast to diploid C. albicans, tetraploid genome size changes we detect are predominantly losses in DNA content and are found in all drug treatments. The low concentration of fluconazole had the greatest impact, with nearly 40% of single colony isolates displaying small reductions in genome size (Fig. 3D ). We also examined genome size changes associated with longer exposures to antifungal drugs (Fig. S4 ). While, we still detect a substantial number of single colony isolates derived from tetraploid C. albicans following caspofungin exposure that show genome size changes, instead of small the reductions in genome size that we detected at 24-hours, we now observe that most isolates have undergone massive genome reductions (Fig. S4B & D) .
As caspofungin frequently induced large-scale genome size changes, we wanted to test whether these changes resulted from a direct genotoxicity of caspofungin or from cell wall stress, so we measured the frequency and magnitude of genome size changes when cells are exposed to calcofluor white. We found that 24-hour exposure to calcofluor white induced genome size changes in ~14% of diploid derived single colony isolates; half of which are gains in DNA content and half of which are losses ( Fig. 3C ). However, genome size shifts are not detected at 120 hours of exposure, and may only exist transiently. In contrast, we observe that 50% of tetraploid derived single colony isolates reduced in genome size following 24 hour exposure to calcofluor white and ~20% at 120 hours ( Fig. 3D & Fig. S4D ). Taken together, these results support a model that organismal ploidy state and the type of stress that the organism is exposed to, determines the effects and magnitude of the mutagenesis.
Discussion
Stress-induced mutagenesis and organismal ploidy state both impact mutation rates and spectrum, but these two phenomena have often only been studied in isolation. Here, we investigated how antifungal drug stress impacts both mutation rates for small-and large-scale genomic events in diploid and tetraploid C. albicans. We find a significant interaction between ploidy and antifungal drug stress on genome instability ('interaction' p = 0.0160, two-way ANOVA, Fig S2) . Specifically, we observe that caspofungin greatly increases genome instability in both diploid and tetraploid C. albicans, albeit to varying degrees, while fluconazole modestly elevates genome instability in tetraploids and not at all in diploids. Our findings support the model that organismal ploidy state impacts genome perturbations induced by specific stressors and this stress-induced increase in genetic variation has the potential for adaptive mutations to quickly arise.
While the genomic response to fluconazole has been well-studied in diploids and to a limited degree in tetraploids (Forche et al. 2011; Harrison et al. 2014; Hickman et al. 2015; Popp et al. 2017 ) the impact of caspofungin on C. albicans mutation rates is less understood, and is mostly investigated in regards to mutations conferring drug resistance. We found that the rate of LOH (Fig. 2) and rate of point mutations (Table S1 ) was substantially elevated in both diploid and tetraploid cells grown in the presence of caspofungin compared to no-drug and fluconazole.
Furthermore, exposure to caspofungin elicits genome size changes in both diploid and tetraploids compared to no drug (Fig. 3, Fig. S4 ). These unexpected findings prompted us to test if caspofungin directly causes genotoxicity or if increased genome instability is an indirect result from stress to the cell wall. We found a similar increase in genome instability when cells were exposed to calcofluor white, which interferes with the proper construction of the fungal cell wall (Walker et al. 2008) (Figs. 2 and 3) . This is consistent with the premise that the increased mutagenesis is an indirect consequence of cell wall stress and not due to a direct genotoxicity of caspofungin.
Exposure to different concentrations of caspofungin results in a 'paradoxical effect' on growth in several pathogenic fungi, including C. albicans and is a phenomenon in which cells can reconstitute growth in concentrations of caspofungin above the MIC, while remaining susceptible to caspofungin (Wagener and Loiko 2017) . We observe a similar effect in our experiments for both diploids and tetraploids. We detect higher CFUs in 2.5 ug/mL caspofungin compared to 0.25 ug/mL caspofungin ( Fig. 1 ) and lower LOH rates and frequency of ploidy change in the higher concentration. This suggests that low concentrations of caspofungin are more stressful than higher doses. There is evidence that Candida albicans restructure its cell wall in response to higher doses of caspofungin in order to better mediate this stress (Walker et al. 2008; Wagener and Loiko 2017) .This caspofungin-mediated cell wall restructuring, in conjunction with our observed reduced genome instability at high caspofungin concentrations is consistent with the premise that high concentrations of caspofungin are less stressful and elicit weaker stress-induced mutagenesis than lower caspofungin concentrations.
While exposure to caspofungin elevated rates of mutagenesis in both diploids and tetraploids, the degree to which these ploidy states are impacted is different. Tetraploid genomes are inherently more unstable than diploid genomes (Hickman et al. 2015; Gerstein et al. 2017 ) and we also observe ~30-fold increase in the rate of LOH in tetraploids compared to diploids in the absence of antifungal drugs (Fig 2) . When comparing the rate of LOH between tetraploids and diploids across the stressors, we see a significantly higher fold-increase (compared to 30-fold in no-drugs) upon exposure to both caspofungin and fluconazole. This effect is particularly exaggerated in fluconazole, where the LOH increases by 3-fold in tetraploids but does not change diploids. We also see substantially more genome size changes associated with tetraploidy compared to diploidy regardless of how long cells are exposed to stressors. Most drastically, 70% of tetraploid isolates reduced to ~diploid in size following five days of caspofungin and 30% due to calcofluor white exposure, but we did not detect any large scale changes in diploids under those conditions and timeframe (Fig S4C & D) . While we detected rampant genome size changes in tetraploids during short exposures to fluconazole and calcofluor white, we did not see these changes persist at longer timeframes. While the overall frequency and scale of genome size changes in diploids exposed to fluconazole was lower, it was similar at 24-hour and five-day exposures. Together, these results suggest that there are interactions between ploidy and antifungal drugs that govern genome instability in C.
albicans.
Several recent studies have implicated a role for ploidy in facilitating resistance to fluconazole. For example, drug-resistant clinical isolates are frequently aneuploid (Selmecki et al. 2006a (Selmecki et al. , 2009 or even polyploidy (Abbey et al. 2014) . Whether these aneuploid drug-resistant clinical isolates result from mis-segregation events in a diploid cell or from parasexual ploidy reduction (Forche et al. 2008; Hickman et al. 2015) of tetraploid cells in the host remains unclear. However in vitro, tetraploids rapidly, yet transiently, arise in response to high doses of fluconazole by decoupling cell growth and DNA replication, leading to trimeric structures and defects in budding (Harrison et al. 2014) . Tetraploids can also arise in vitro via mating and potentially combine drug-resistant alleles that arose independently in diploid cells to generate mating products with even greater increases in their fluconazole MIC, (Popp et al. 2019) .
Regardless of whether the mechanism of tetraploid formation is mediated by mating or mitotic defects, the very high degree of tetraploid genome instability, particularly under antifungal drug stress, can generate aneuploidy and may facilitate resistance to fluconazole. In S. cerevisiae, tetraploids adapt much rapidly to nutrient-limited environments (Selmecki et al. 2015) and in C. albicans, stress-induced ploidy transitions have been proposed as a strategy for accelerating adaptation in this opportunistic fungal pathogen (Berman and Hadany 2012) . Here we show that tetraploids generate a more diverse repertoire of mutations and at higher frequencies than diploids, particularly in response to azole and echinocandin drugs, and likely facilitate the rapid emergence of antifungal drug resistance.
Materials and Methods
Yeast strains and media
The stains used in this study are listed in Table S1 . MH297 was constructed by replacing the wildtype HIS4 open reading frame with the dominant drug-resistant NAT gene by lithium acetate transformation. Transformants were selected on YPD containing 50 ug/mL NAT and replica plated to media lacking histidine to identify candidates whose wildtype HIS4 genes was replaced. MH296 is the mating product of two his4Δ:: NAT/his4-G929T diploid strains. All strains were stored as glycerol stocks −80°C and maintained on YPD medium (1% yeast extract, 2% bactopeptone, 2% glucose, 1.5% agar, 0.004% adenine, 0.008% uridine) at 30°C.
For the assays in which antifungals were used, 1 mg/mL fluconazole stocks were made from powder (ACROS Organics CAS#86386-73-4) and diluted into DMSO. 1 mg/mL caspofungin stocks (Sigma-Aldrich CAS#179463-17-3) and 10mg/mL calcofluor white stocks (Sigma-Aldrich CAS#4404-43-7) were also made from powder and diluted into ddH20. Liquid yeast cultures were grown in casitone (0.9% bacto-casitone, 0.5% yeast extract, 1% sodium citrate, 2% glucose), with or without antifungals. Plating on synthetic complete media (SDC) was used for enumerating total CFUs following drug exposure (0.17% yeast nitrogen base without amino acids or ammonium sulfate, 0.5% ammonium sulfate, 2 sodium hydroxide pellets, 0.004% uridine, 0.2% synthetic complete media, 2% agar, 2% glucose).
Drug susceptibility
The minimum inhibitory concentration (MIC) for each strain was performed as previous described (Rosenburg et. al 2018) with the following modifications. Single colonies were inoculated in liquid YPD and incubated at 30°C with shaking for ~16 h. Cultures subsequently normalized to 1 OD in casitone and serially diluted (two, 10-fold serial dilutions with 100 µl culture : 900 µl ddH20 (10 -1 and 10 -2 ). 200uL of the diluted cells were plated onto casitone plates containing 1% agar and left to dry for 10 minutes before placing standardized E-test strips (Biomeureix) of caspofungin (gradient 0.002 ug/mL -32 ug/mL) and fluconazole (gradient 0.016 ug/mL -256 ug/mL). Plates were incubated at 30°C and photographed after 24 h growth.
HIS4 reversion
The rate of his4-G929T reversion was performed as previously described (Forche et al 2011) with the following modifications. Ten single colonies of MH296 and MH297 were inoculated into 6 mL liquid YPD and incubated at 30°C with shaking for 24 h. 1 mL of the overnight culture was added to 4 mL of the following casitione media: no drug, 1 ug/mL fluconazole, 10 ug/mL fluconazole, 0.25 ug/mL caspofungin, 2.5 ug/mL caspofungin, and 100 ug/mL calcofluor white. All cultures were subsequently grown at 30°C with shaking for 5 days.
To determine the number of viable colonies, 500 uL of each culture was serially diluted and plated on 100 x 15mm SDC plates. To determine the number of HIS revertants, the remaining 4.5 mL of each culture was harvested by centrifugation, washed with H2O, resuspended in 300uL ddH20 and plated onto 150mm x 15mm SDC -His plates. Plates were incubated at 30°C for 48 h. The rate of reversion was determined by fluctuation analysis using Luria-Delbruck method (Luria and lbrück 1943) . All reversion experiments were performed in triplicate. A minimum of 48 single colonies per strain/ploidy were picked from SDC plates and stored as glycerol stocks for subsequent flow cytometry analysis.
GAL1 loss of heterozygosity
The rate of GAL1 loss of heterozygosity (LOH) was performed as previously described (Hickman et al 2015) with the following modifications. Twelve single colonies of MH84 and MH128 were inoculated into 2 mL casitone in the presence or absence of drugs. The cultures incubated at 30°C for 24h and harvested by centrifugation, washed once with ddH20 and resuspended in 1mL ddH20. 100 uL of the appropriate dilutions, (10 -5 for no drug, 10 -4 for fluconazole and 10 -2 for caspofungin and calcofluor white treated cultures, of each culture was plated onto SDC to determine total cell viability, and onto 2-deoxygalactose (10 -1 for no drug, 10 -1 for fluconazole and 10 0 for caspofungin and calcofluor white treated cultures (2-DOG; 0.17% yeast nitrogen base without amino acids, 0.5% ammonium sulfate, 0.004% uridine, 0.004% histidine, 0.006% leucine, 0.1% 2-deoxygalactose, 3% glycerol) to select for cells that spontaneously lost GAL1 during the previous overnight growth in the presence or absence of antifungal drugs. SDC CFUs plated on SDC were counted following 48 h, and CFUs plated on 2-DOG were counted following 72 h growth. Rates of LOH were determined by the method of the median (Lea and Coulson 1949) . All LOH experiments were performed in triplicate. At least 48 single colonies per strain/ploidy were picked from SDC plates and stored as glycerol stocks for subsequent flow cytometry analysis.
Flow cytometry
Flow cytometry analysis was performed as previously published (Hickman et al. 2015) . Briefly, 200uL of cells in midlog-phase were harvested, washed with distilled water, and resuspended in 20uL of 50 mM Tris (pH 8):50 mM EDTA (50:50 TE). Cells were fixed with 95% ethanol and incubated at 4° overnight. Cells were washed twice with 50:50 TE, resuspended in 50µL of 1 mg/ml RNAse A and incubated at 37° for 1 h. Cells were then collected, resuspended in 50µL of 5 mg/ml Proteinase K, and incubated at 37° for 30 m. Cells were subsequently washed once with 50:50 TE, resuspended in 50µL SybrGreen (1:100 of dilution in 50:50 TE), (Lonza, CAT#12001-798, 10,000x concentrated) incubated at 4° overnight collected via centrifugation and resuspended in 150 µL 50:50 TE, briefly sonicated, and run on a LSRII machine with laboratory diploid (MH1) and tetraploid (MH2) strains serving as calibration and internal controls.
To estimate the average G1 peak FITC intensity, the multi-Gaussian cell cycle model used (FloJoV10).
Statistical analysis
Statistical analysis was performed using GraphPad Prism 8 software. Comparisons to no-stress were performed using non-parametric, unpaired, Mann-Whitney U-test. A) Total diploid genome size. Diploid genome size was measured after 24hrs of drug exposure using flow cytometry, with the G1 peak plotted in a.u (arbitrary units). The gray line represents the mean of the diploid no drug control, (n = 189) and the tetraploid no -drug control (n = 178) +/-1 SD. Each symbol represents the genome size average of 10,000 events from one culture (1 ug/mL FLU, n = 96, 10 ug/mL FLU, n = 89, 0.25 ug/mL CAS, n = 86, 2.5 ug/mL CAS, n = 93. 100 ug/mL CW, n = 90). The bold line represents the mean across all of the samples. Askrisks indicate statistical signifance compared to the no-drug control (gray bars), Mann-Whitney U-test. B) Same as A, using tetraploid strain (no stress, n = 87, 1 ug/mL FLU, n = 93, 10 ug/mL FLU, n = 96, 0.25 ug/mL CAS, n = 82, 2.5 ug/mL CAS, n = 96, 100 ug/mL CW, n = 96.) C) Quantification of diploid genome size changes. The percentage of diploids samples (from A) that show genome size changes after 24hrs was calculated as any sample that showed a genome size difference after drug treatment that was 2-standard deviations away from the mean of the no-drug diploid control. D) Quantification of tetraploid genome size changes. Calculated and presented same as in (C). Table S1 : his4-G929T reversion rates in diploid and tetraploid C. albicans. The reversion rate was determined by fluctuation analysis using Luria-Delbruck Method (Luria S, Delbrück M 1943 and Spell and Jinks-Robertson, Molecular Biology 2004) . The numbers represent the mean value across the experiments, while the number in parenthesis is the standard deviation across the independent trials. The 'n' value represents the number of independent experiments in which reversion events were observed.
D. C.
Diploid
Strain
Genotype References
Diploids
MH84
MTLα/α; ura3::imm434::URA3/ura3::imm434; iro1::IRO1/iro1::imm434; his1Δ::hisG/his1Δ::hisG; leu2Δ/leu2Δ; GAL1/gal1Δ::SAT1 (Hickman et.al. 2015) MH297 MTLa/α; HIS4Δ::NAT/his4-G929T This Study
Tetraploids
MH128
MTLα/α/a/Δ; ura3Δ/ura3Δ/URA3/URA3, HIS1/HIS1/his1Δ::hisG/his1Δ::hisG; LEU2/LEU2/leu2Δ/leu2Δ; ENO1-GFP:NAT/ENO1/ENO1/ENO1; gal1Δ/gal1Δ/gal1Δ/GAL1; (Hickman et. al 2015) MH296 MTLa/alpha1Δ-alpha2Δ/MTLa1Δ-a2Δ/alpha; ura3Δ::λimm434/ura3Δ::λimm434/URA3/ura3; ade2::hisG/ade2::hisG/ADE2/ade2gal1::hisG/gal1::hisG/GAL1/gal1; his4Δ::NAT/his4-G929T/HIS4Δ::NAT/his4-G929T This study Table S2 : Strains used in this study.
